Key result
ClearSight enables continuous noninvasive hemodynamic tracking during electroconvulsive therapy across repeated sessions.
Why the study?
The study aimed to demonstrate the feasibility of continuous noninvasive blood pressure monitoring with the ClearSight System during ECT and evaluate hemodynamic changes across multiple sessions to enable prediction and preemptive treatment.
Is continuous noninvasive hemodynamic monitoring using the ClearSight System feasible for assessing hemodynamic changes during electroconvulsive therapy?
RCT (n=14)
Is continuous noninvasive hemodynamic monitoring using the ClearSight System feasible for assessing hemodynamic changes during electroconvulsive therapy?
Continuous noninvasive hemodynamic monitoring is feasible during ECT and can predict individual hemodynamic responses across multiple sessions.
Answers are grounded in this paper and cite their sources.
Supports feasibility of noninvasive hemodynamic monitoring in ECT; leaves open whether adoption improves outcomes in prospective trials.
OBJECTIVES: First aim was to demonstrate feasibility of continuous noninvasive blood pressure monitoring using the ClearSight System (Edwards Lifesciences Corp) in the setting of electroconvulsive therapy (ECT). Second aim was to evaluate the hemodynamic changes over multiple ECT sessions, allowing prediction and preemptive treatment of hemodynamic changes to reduce cardiovascular stress in subsequent sessions. METHODS: In a subset of an ongoing RCT, patients' hemodynamic parameters were recorded using the ClearSight System™ from induction of anesthesia for up to 10 minutes. RESULTS: One hundred forty-nine sessions in 14 patients were recorded. Hemodynamic monitoring using the ClearSight System was feasible in all patients with limitation of poor peripheral perfusion due to Raynaud syndrome in one patient and recording gaps in case of poor muscle relaxation. Hemodynamic patterns varied widely between individuals, but were comparable over multiple ECT sessions. CONCLUSIONS: Individual hemodynamic reactions can be precisely assessed using the ClearSight System with only minor limitations. Given the similar hemodynamic reaction over repeated sessions, a single measurement can be used to predict subsequent reactions and to preemptively treat cardiovascular changes without the need to use costly consumables over multiple sessions.
No takes yet. Share an insight, caveat, or question.
Bindernagel et al. (2025) conducted an RCT in Patients undergoing electroconvulsive therapy (ECT) (n=14). Continuous noninvasive blood pressure monitoring using the ClearSight System was evaluated on Feasibility of continuous noninvasive blood pressure monitoring and evaluation of hemodynamic changes. Continuous noninvasive hemodynamic monitoring using the ClearSight System was feasible in all 14 patients during ECT, showing comparable individual hemodynamic patterns over multiple sessions.
Synapse has enriched 10 related papers. Consider them for comparative context: